ABOUT VHIO

VHIO is a leading comprehensive cancer center of excellence where its scientists and physicians adopt a purely translational research model, working together as multidisciplinary teams to both accelerate and advance personalized and targeted therapies against cancer:

DISCOVER MORE

PROGRAMS & GROUPS

Scientific activity at VHIO is structured across for major programs: Preclinical, Translational, Clinical Research, and Core Technologies. Each incorporates research teams of excellence dedicated to harnessing and rapidly translating discoveries into tangible benefits for patients.

MEET VHIO´S TEAMS

NEWS

CheckMate 9ER: potentially practice-changing data for the treatment of metastatic renal cell carcinoma

19/09/2020|Comments Off on CheckMate 9ER: potentially practice-changing data for the treatment of metastatic renal cell carcinoma

New therapeutic options with immunotherapy for patients with gynaecological neoplasms

18/09/2020|Comments Off on New therapeutic options with immunotherapy for patients with gynaecological neoplasms

Spin-off Reveal Genomics born to develop innovative diagnostic tests in oncology

18/09/2020|Comments Off on Spin-off Reveal Genomics born to develop innovative diagnostic tests in oncology

The UITM- “la Caixa” of the VHIO is presenting various studies focused on improving the efficacy of immunotherapy treatments

18/09/2020|Comments Off on The UITM- “la Caixa” of the VHIO is presenting various studies focused on improving the efficacy of immunotherapy treatments

Let’s Team up for Cancer Research: lend your support to this year’s World Cancer Research Day campaign running from 17-24 September

16/09/2020|Comments Off on Let’s Team up for Cancer Research: lend your support to this year’s World Cancer Research Day campaign running from 17-24 September

ESMO Virtual Annual Congress’ not-to-be-missed W4O’s Women in Science Program

10/09/2020|Comments Off on ESMO Virtual Annual Congress’ not-to-be-missed W4O’s Women in Science Program

SEE ALL NEWS

Follow us:

DIRECTION &
PRINCIPAL INVESTIGATORS

Research at VHIO is led by our Director, Josep Tabernero, and supported by a consultative body, VHIO’s Scientific Committee. A total of 26 renowned Principal Investigators manage and run VHIO’s major research themes and programs.

BROWSE OUR PIS

SCIENTIFIC
REPORT
2018

LAUNCH

CLINICAL TRIALS

Driving drug development & targeted therapies against cancer, VHIO has become a leading reference in drug discovery from concept to clinic:

CLINICAL TRIALS OFFICE
RESEARCH UNIT FOR MOLECULAR THERAPY OF CANCER – “LA CAIXA”
CURRENTLY OPEN TRIALS

PROJECTS & INSTITUTIONAL PROGRAMS

Research at VHIO is made possible through the support received from private institutions, funding entities, companies and individuals, as well as International and National Competitive Grants. Find out more about our supporters, current projects and VHIO´s Scientific Coordination Area:

CURRENT PROJECTS
FERO FOUNDATION’S ADVANCED MOLECULAR DIAGNOSTICS PROGRAM
BBVA FOUNDATION’S IMMUNOTHERAPY & IMMUNOLOGY PROGRAM (CAIMI)
“LA CAIXA” INTL RESEARCH & EDUCATION PROGRAM
SCIENTIFIC COORDINATION

EVENTS

VHIO organizes symposia of excellence and ad-hoc courses & workshops through which it shares its expertise and promotes debate and exchange of the highest degree:

VHIO – ”LA CAIXA” SCIENTIFIC SEMINARS SERIES
INTERNATIONAL SYMPOSIA
WORKSHOPS & COURSES
BENCHSTORMING SEMINARS